Hyperfine (HYPR) Revenue & Revenue Breakdown
Hyperfine Revenue Highlights
Latest Revenue (Y)
$12.89M
Latest Revenue (Q)
$2.32M
Main Segment (Y)
Product
Main Geography (Y)
Non-US
Hyperfine Revenue by Period
Hyperfine Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $12.89M | 16.84% |
| 2023-12-31 | $11.03M | 61.90% |
| 2022-12-31 | $6.81M | 355.48% |
| 2021-12-31 | $1.50M | 408.84% |
| 2020-12-31 | $294.00K | 100.00% |
| 2019-12-31 | - | - |
Hyperfine generated $12.89M in revenue during NA 2024, up 16.84% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Hyperfine Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $2.32M | -36.29% |
| 2024-09-30 | $3.64M | 0.33% |
| 2024-06-30 | $3.63M | 10.20% |
| 2024-03-31 | $3.29M | 22.67% |
| 2023-12-31 | $2.69M | 15.28% |
| 2023-09-30 | $2.33M | -31.09% |
| 2023-06-30 | $3.38M | 28.31% |
| 2023-03-31 | $2.63M | 85.04% |
| 2022-12-31 | $1.42M | -39.35% |
| 2022-09-30 | $2.35M | 53.16% |
| 2022-06-30 | $1.53M | 1.59% |
| 2022-03-31 | $1.51M | 246.10% |
| 2021-12-31 | $436.00K | 17.52% |
| 2021-09-30 | $371.00K | 3.63% |
| 2021-06-30 | $358.00K | 8.16% |
| 2021-03-31 | $331.00K | 59.90% |
| 2020-12-31 | $207.00K | 459.46% |
| 2020-09-30 | $37.00K | 48.00% |
| 2020-06-30 | $25.00K | - |
| 2020-03-31 | $25.00K | - |
Hyperfine generated $2.32M in revenue during Q4 2024, up -36.29% compared to the previous quarter, and up 99.61% compared to the same period a year ago.
Hyperfine Revenue Breakdown
Hyperfine Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Service | $2.44M |
| Product | $10.45M |
Hyperfine's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (81.07%), and Service (18.93%).
Quarterly Revenue by Product
| Product/Service | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 |
|---|---|---|---|---|---|---|---|
| Product | $1.52M | $4.71M | $3.03M | $2.70M | $1.73M | $2.81M | - |
| Service | $615.00K | $1.24M | $610.00K | $591.00K | $602.00K | $114.00K | - |
Hyperfine's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product (71.22%), and Service (28.78%).
Hyperfine Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| Non-US | $6.39M | $4.36M | $2.54M | - |
| AUSTRALIA | - | - | - | $78.00K |
Hyperfine's latest annual revenue breakdown by geography, as of Dec 24: Non-US (100.00%).
Quarterly Revenue by Country
| Country | Mar 25 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-US Countries | $1.07M | $1.16M | $2.43M | $65.00K | $2.90M | $1.03M | $784.00K | $561.00K | - | - |
| Service | - | - | - | - | - | $114.00K | - | - | - | - |
| Non-US | - | - | - | - | - | - | $591.00K | - | - | - |
| Canada and Pakistan | - | - | - | - | - | - | - | - | - | $509.00K |
Hyperfine's latest quarterly revenue breakdown by geography, as of Mar 25: Non-US Countries (100.00%).
Hyperfine Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAVM | PAVmed | $3.00B | $979.00M |
| ITGR | Integer | $1.72B | $437.39M |
| LIVN | LivaNova | $1.25B | $321.80M |
| INGN | Inogen | $335.70M | $80.08M |
| KIDS | OrthoPediatrics | $204.73M | $52.67M |
| ANIK | Anika Therapeutics | $166.66M | $-1.29M |
| SRDX | Surmodics | $126.08M | $28.09M |
| LUNG | Pulmonx | $83.79M | $22.54M |
| NPCE | NeuroPace | $79.91M | $21.47M |
| IRMD | IRadimed | $73.24M | $19.51M |
| APYX | Apyx Medical | $48.10M | $14.22M |
| HYPR | Hyperfine | $12.89M | $2.32M |
| OFIX | Orthofix Medical | - | $215.66M |